Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 SEK | +2.99% | +10.71% | +93.75% |
19/04 | Pila Pharma Appoints New CEO, Chief Scientific Officer | MT |
19/04 | Pila Pharma AB Announces Board and Management Appointments | CI |
Business Summary
Number of employees: 1
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
TRPV1 Antagonist
100.0
%
| 2 | 100.0 % | 1 | 100.0 % | -22.21% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 2 | 100.0 % | 1 | 100.0 % | -22.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dorte Xenia Gram
FOU | Founder | 55 | 01/14/01 |
Director of Finance/CFO | 63 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 01/16/01 | |
Søren Weis Dahl
BRD | Director/Board Member | 58 | 30/23/30 |
Dorte Xenia Gram
FOU | Founder | 55 | 01/14/01 |
Director/Board Member | 57 | 30/23/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,793,289 | 12,950,660 ( 54.43 %) | 0 | 54.43 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+93.75% | 7M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- PILA Stock
- Company Pila Pharma AB